Cancer 2035: A Roadmap for the Future

February 23-24, 2026

Washington, DC

Co-hosted by the Milken Institute and the Richard Nixon Foundation, Cancer 2035: A Roadmap for the Future brings together leading oncologists, researchers, policymakers, and influential industry experts to examine how today’s scientific and technological capabilities can drive the next era of biomedical progress.

The event coincides with a pivotal milestone: the 55th anniversary of the National Cancer Act, landmark legislation that transformed the nation’s approach to cancer and set in motion decades of scientific and clinical progress.

Join health leaders as they discuss what it would take—in research, technology, policy, financing, and care delivery—to dramatically reduce cancer mortality by 2035.

Leaders across science, medicine, policy, technology, finance, and philanthropy are gathering seek to chart a new path for the future of cancer prevention, research, and care and assess how the cancer model of discovery can accelerate breakthroughs across all diseases. This gathering coincides with a pivotal milestone: the 55th anniversary of the National Cancer Act, landmark legislation that transformed the nation’s approach to cancer and set in motion decades of scientific and clinical progress. As we mark this anniversary, the central question is how we harness today’s scientific and technological capabilities to drive the next era of discovery. The anniversary is both a reminder of what coordinated national action can achieve and a call to design the next generation of systems, strategies, and partnerships needed to accelerate biomedical progress.

Watch the event discussion: